First Pacific Advisors’s Myriad Genetics MYGN Stock Holding History

First Pacific Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-233,200	Closed	-$7.93M	–	142
2015 Q2	$7.93M	Sell	233,200 -17,900	-7%	-$609K	0.06%	80
2015 Q1	$8.89M	Hold	251,100	–	–	0.07%	83
2014 Q4	$8.55M	Hold	251,100	–	–	0.07%	81
2014 Q3	$9.69M	Hold	251,100	–	–	0.08%	88
2014 Q2	$9.77M	Hold	251,100	–	–	0.08%	90
2014 Q1	$8.59M	Hold	251,100	–	–	0.08%	93
2013 Q4	$5.27M	Buy	251,100 +114,600	+84%	+$2.9M	0.05%	94
2013 Q3	$3.21M	Buy	+136,500	New	+$3.88M	0.03%	96

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Pacific Advisors's MYGN Position: Q3 2015 in Review

First Pacific Advisors sold out of Myriad Genetics (MYGN) in Q3 2015, closing a stake of 233,200 shares — an estimated $7.93M sold.

First Pacific Advisors first reported a position in MYGN in Q3 2013 and held it in 8 quarters. The position peaked at $9.77M in Q2 2014. 234 funds tracked by Wall St. Rank hold MYGN as of Q3 2015.

First Pacific Advisors reported no remaining Myriad Genetics position as of Q3 2015 after selling out during the quarter.
First Pacific Advisors sold 233,200 Myriad Genetics shares in Q3 2015, an estimated $7.93M.
First Pacific Advisors first reported a position in Myriad Genetics in Q3 2013 and held it in 8 quarters.
First Pacific Advisors's Myriad Genetics position peaked at $9.77M in Q2 2014.
234 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2015.

Based on First Pacific Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.